We are live on ! Find out more
DCP

DSM Capital Partners Portfolio holdings

AUM $5.66B
1-Year Est. Return 27.45%
This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+27.45%
3 Year Est. Return
+126.04%
5 Year Est. Return
+156.94%
10 Year Est. Return
+722.36%
AUM
$5.42B
AUM Growth
+$384M
Cap. Flow
+$7.1M
Cap. Flow %
0.13%
Top 10 Hldgs %
51%
Holding
79
New
3
Increased
18
Reduced
24
Closed
33

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$217M
2
YUM icon
Yum! Brands
YUM
+$133M
3
MNST icon
Monster Beverage
MNST
+$130M
4
BLK icon
Blackrock
BLK
+$102M
5
MA icon
Mastercard
MA
+$17.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.26%
2 Communication Services 16.4%
3 Consumer Discretionary 15.73%
4 Financials 12.8%
5 Consumer Staples 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$561M 10.35%
5,016,007
-41,381
-0.8% -$4.36M
BIIB icon
2
Biogen
BIIB
$30.9B
$305M 5.62%
898,165
+128,837
+17% +$41.7M
TWX
3
DELISTED
Time Warner Inc
TWX
$297M 5.47%
3,472,442
+1,882,428
+118% +$150M
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
$294M 5.42%
1,587,816
-10,220
-0.6% -$1.89M
BKNG icon
5
Booking.com
BKNG
$156B
$274M 5.06%
6,012,850
+613,700
+11% +$27.7M
BABA icon
6
Alibaba
BABA
$276B
$224M 4.13%
2,154,108
+584,088
+37% +$59.9M
REGN icon
7
Regeneron Pharmaceuticals
REGN
$72.9B
$212M 3.91%
516,939
-3,308
-0.6% -$1.3M
BIDU icon
8
Baidu
BIDU
$35.7B
$203M 3.75%
890,977
+830,077
+1,363% +$190M
CTSH icon
9
Cognizant
CTSH
$25.2B
$200M 3.7%
3,806,589
-83,296
-2% -$4.16M
V icon
10
Visa
V
$677B
$195M 3.6%
2,973,996
-23,484
-0.8% -$1.41M
SBUX icon
11
Starbucks
SBUX
$119B
$186M 3.42%
4,522,158
-110,378
-2% -$4.31M
GOOG icon
12
Alphabet (Google) Class C
GOOG
$4.11T
$183M 3.37%
6,937,856
-357,037
-5% -$9.58M
PCP
13
DELISTED
PRECISION CASTPARTS CORP
PCP
$179M 3.3%
742,054
-15,083
-2% -$3.48M
PRGO icon
14
Perrigo
PRGO
$1.44B
$161M 2.98%
964,906
+227,847
+31% +$35.6M
MON
15
DELISTED
Monsanto Co
MON
$157M 2.9%
1,314,080
+4,207
+0.3% +$489K
ABT icon
16
Abbott
ABT
$187B
$156M 2.87%
3,455,731
+375,230
+12% +$16.3M
CMCSA icon
17
Comcast
CMCSA
$87.3B
$146M 2.69%
5,028,018
+1,440,450
+40% +$39.5M
IVZ icon
18
Invesco
IVZ
$12.4B
$141M 2.61%
3,580,239
-17,912
-0.5% -$706K
DLTR icon
19
Dollar Tree
DLTR
$24.8B
$139M 2.56%
1,970,735
+828,892
+73% +$52.3M
MA icon
20
Mastercard
MA
$498B
$134M 2.48%
1,559,183
-218,686
-12% -$17.9M
MNST icon
21
Monster Beverage
MNST
$95.1B
$130M 2.4%
7,206,642
-7,555,710
-51% -$130M
AMG icon
22
Affiliated Managers Group
AMG
$9.51B
$117M 2.16%
551,809
+543,109
+6,243% +$108M
DG icon
23
Dollar General
DG
$28.4B
$88.3M 1.63%
1,248,485
-16,819
-1% -$1.09M
WYNN icon
24
Wynn Resorts
WYNN
$10.3B
$86M 1.59%
578,200
-10,637
-2% -$1.83M
LVS icon
25
Las Vegas Sands
LVS
$31.4B
$83.3M 1.54%
1,432,573
-29,982
-2% -$1.81M

Similar funds

DSM Capital Partners's Q4 2014 Portfolio in Review

As of Q4 2014, DSM Capital Partners held 79 positions worth $5.42B, up 7.6% from $5.04B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

DSM Capital Partners's Q4 2014 filing shows 3 new, 18 increased, 24 reduced and 33 closed positions. Its largest new stake was Check Point Software Technologies: 181,210 shares worth $14.2M. The largest sale was Allergan Inc, an estimated $217M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • DSM Capital Partners's largest Q4 2014 buy was Check Point Software Technologies: 181,210 shares worth $14.2M.
  • DSM Capital Partners added most to Baidu in Q4 2014, an estimated $190M increase.
  • DSM Capital Partners's biggest Q4 2014 reduction was Monster Beverage, cutting an estimated $130M.
  • DSM Capital Partners fully exited Allergan Inc in Q4 2014, selling an estimated $217M.
  • DSM Capital Partners's ten largest holdings make up 51% of its $5.42B portfolio in Q4 2014.
  • DSM Capital Partners opened 3 new positions and closed 33 in Q4 2014.
  • DSM Capital Partners's portfolio value rose 7.6% quarter-over-quarter to $5.42B.

Based on DSM Capital Partners's 13F filing for Q4 2014, filed 12 Feb 2015.